CoMFA/CoMSIA/HQSAR and docking study of the binding mode of selective cyclooxygenase (COX-2) inhibitors

被引:26
作者
Chen, HF
Li, Q
Yao, XJ
Fan, BT
Yuan, SG
Panaye, A
Doucet, JP
机构
[1] Univ Paris 07, CNRS UMR 7086, ITODYS, F-75005 Paris, France
[2] Chinese Acad Sci, Shanghai Inst Organ Chem, Key Lab Comp Chem, Shanghai 200032, Peoples R China
来源
QSAR & COMBINATORIAL SCIENCE | 2004年 / 23卷 / 01期
关键词
cyclooxygenase (COX-2) inhibitors; docking; 3D-QSAR; HQSAR;
D O I
10.1002/qsar.200330844
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The intermolecular interaction between four types of anti-inflammatory inhibitors (oxazoles, pyrazoles, pyrroles and imidazoles) and COX-2 receptor was studied. The results of docking suggest that they have similar interaction mechanism. The most active compounds of these four types of inhibitors could both form several hydrogen bonds with residues His90, Arg513, Leu352 and Arg120, and develop hydrophobic interaction with residues Phe518, Leu352 and Leu359. This is consistent with the investigation reported by R. G. Kurumbail et al. (Nature. 1996, 384, 644-648). A common 3D-QSAR model could be constructed with these four categories of COX-2 inhibitors using the method of docking- guided conformer selection. The cross-validated q(2) values are found as 0.741 and 0.632 for CoMFA and CoMSIA respectively. And the non-cross-validated r(2) values are 0.887 and 0.885. 54 inhibitors constitute the test set used to validate the model. The results show that this model possesses good predictive ability for diverse COX-2 inhibitors. Furthermore, a HQSAR model was used to evaluate the influence of substituents on anti-inflammatory activity. Compared with the results of previous works, our model possesses significantly better prediction ability. It could help us to well understand the interaction mechanism between inhibitors and COX-2 receptor, and to make quantitative prediction of their inhibitory activities.
引用
收藏
页码:36 / 55
页数:20
相关论文
共 36 条
[11]   4-(4-cycloalkyl/aryl-oxazol-5-yl)benzenesulfonamides as selective cyclooxygenase-2 inhibitors:: Enhancement of the selectivity by introduction of a fluorine atom and identification of a potent, highly selective, and orally active COX-2 inhibitor JTE-5221 [J].
Hashimoto, H ;
Imamura, K ;
Haruta, J ;
Wakitani, K .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (07) :1511-1517
[12]  
Heritage TW., 1999, Rational Drug Design, V917, P212
[13]   Spectral and crystallographic study of pyridinic analogues of nimesulide:: Determination of the active form of methanesulfonamides as COX-2 selective inhibitors [J].
Julémont, F ;
de Leval, X ;
Michaux, C ;
Damas, J ;
Charlier, C ;
Durant, F ;
Pirotte, B ;
Dogné, JM .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (23) :5182-5185
[14]   1,2-diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2 [J].
Khanna, IK ;
Weier, RM ;
Yu, Y ;
Collins, PW ;
Miyashiro, JM ;
Koboldt, CM ;
Veenhuizen, AW ;
Currie, JL ;
Seibert, K ;
Isakson, PC .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (11) :1619-1633
[15]   1,2-diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents [J].
Khanna, IK ;
Weier, RM ;
Yu, Y ;
Xu, XD ;
Koszyk, FJ ;
Collins, PW ;
Koboldt, CM ;
Veenhuizen, AW ;
Perkins, WE ;
Casler, JJ ;
Masferrer, JL ;
Zhang, YY ;
Gregory, SA ;
Seibert, K ;
Isakson, PC .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (11) :1634-1647
[16]   Selective cyclooxygenase-2 inhibitors: Heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents [J].
Khanna, IK ;
Yu, Y ;
Huff, RM ;
Weier, RM ;
Xu, XD ;
Koszyk, FJ ;
Collins, PW ;
Cogburn, JN ;
Isakson, PC ;
Koboldt, CM ;
Masferrer, JL ;
Perkins, WE ;
Seibert, K ;
Veenhuizen, AW ;
Yuan, JH ;
Yang, DC ;
Zhang, YY .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (16) :3168-3185
[17]   Comparative Molecular Similarity Index Analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries [J].
Klebe, G ;
Abraham, U .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1999, 13 (01) :1-10
[18]   SELECTIVE-INHIBITION OF CYCLOOXYGENASE-2 [J].
KLEIN, T ;
NUSING, RM ;
PFEILSCHIFTER, J ;
ULLRICH, V .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (08) :1605-1610
[19]   Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents [J].
Kurumbail, RG ;
Stevens, AM ;
Gierse, JK ;
McDonald, JJ ;
Stegeman, RA ;
Pak, JY ;
Gildehaus, D ;
Miyashiro, JM ;
Penning, TD ;
Seibert, K ;
Isakson, PC ;
Stallings, WC .
NATURE, 1996, 384 (6610) :644-648
[20]   Synthesis and biological evaluation of both enantiomers of L-761,000 as inhibitors of cyclooxygenase 1 and 2 [J].
Leblanc, Y ;
Black, WC ;
Chan, CC ;
Charleson, S ;
Delorme, D ;
Denis, D ;
Gauthier, JY ;
Grimm, EL ;
Gordon, R ;
Guay, D ;
Hamel, P ;
Kargman, S ;
Lau, CK ;
Mancini, J ;
Ouellet, M ;
Percival, D ;
Roy, P ;
Skorey, K ;
Tagari, P ;
Vickers, P ;
Wong, E ;
Xu, L ;
Prasti, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (06) :731-736